Market Research Report
NORTH AMERICA BETA GLUCAN MARKET FORECAST 2018-2026
|Published by||Inkwood Research||Product code||636636|
|Published||Content info||94 Pages
Delivery time: 1-2 business days
|NORTH AMERICA BETA GLUCAN MARKET FORECAST 2018-2026|
|Published: May 14, 2018||Content info: 94 Pages||
The North America beta glucan market is expected to progress at a 7.70% CAGR during the forecast period of 2018-2026. The unexploited beta glucan applications in cosmetic and medicine sector are expected to present this market with potential growth opportunities.
The pharmaceutical industry is an important end-user in the North American beta-glucan market. Other key end-users in this market include animal feed, personal care, and food and beverages industry. In 2017, the US market accounted for the highest share in the North America beta-glucan market. It was followed by the Canadian beta-glucan market, which is expected to progress at a CAGR of xx%. The country's growing diabetic population and increasing number of ongoing clinical trials are boosting its market growth.
Pharmacon Asa, Frutarom, Specialty Biotech Ltd, Alltech Biotechnology, Milliporesigma (Merck), Tate & Lyle Plc, Lesaffre Human Care, Cargill Inc, Super Beta Glucan, Kemin Industries and Kerry Group Plc are few of the established market companies in this region.